AGENAgenus Inc.
$6.33+56% 1Y
$6.33
$2.7752 weeks$9.93
Is the price fair?
What AGEN's price assumes
Agenus Inc. trades at 2.45× earnings against 19.8× for the median Biotechnology name, cheaper than its own group.
2.45
Trailing P/E · Biotechnology median 19.8 · cheaper than the typical name in its group
- Price / sales
- 0.95
Price / sales · as of 2026-Q2
- EV / sales
- 1.03
EV / sales
Details›
- EV / EBITas of 2026-Q2
- 3.78
- EV / salesas of 2026-Q2
- 1.03
- Healthcare median P/E503 names
- 27.9
- Biotechnology median P/E242 names
- 19.8
- Market capitalisation45.0 million shares, counted Aug 4, 2026
- $285M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.